Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 13 of 13 for “"Tolcapone"”.

  1. Risk and Benefit Assessment for Tolcapone in the Treatment of Parkinson's Disease

    … for the effectiveness and tolerability of tolcapone in the treatment of Parkinson’s disease. Methods: The literature from 1990 to 2003 was searched systematically to identify randomised trials of tolcapone. Search methods included the Roche intranet to find the most up to date safety …

    aston Repository record for Risk and Benefit Assessment for Tolcapone in the Treatment of Parkinson's Disease (opens in a new tab) Download PDF for Risk and Benefit Assessment for Tolcapone in the Treatment of Parkinson's Disease (opens in a new tab)

  2. Illness Impact and Adjustment to Parkinson's Disease: Before and After Treatment with Tolcapone

    … and adjustment) was improved by treatment with tolcapone in persons with Parkinson's disease. This study was done in parallel with a double-blind placebo controlled study of the efficacy and safety of tolcapone. Quality of life was measured by the Sickness Impact Profile (SIP) and adjustment to …

    usd-thes Repository record for Illness Impact and Adjustment to Parkinson's Disease: Before and After Treatment with Tolcapone (opens in a new tab)

  3. The interaction of COMT genotype, tolcapone and acute stress, on brain activity and working memory performance

    … be altered pharmacologically by inhibitors, like tolcapone. Previous research showed that COMT Val<sup>158</sup>Met affects the functional connectivity of the PFC at rest and linked the COMT-Met allele with better PFC-dependent performance. Moreover, COMT genotype and tolcapone interact, with the …

    oxford Repository record for The interaction of COMT genotype, tolcapone and acute stress, on brain activity and working memory performance (opens in a new tab)

  4. The role of catechol-O-methyltransferase in processing affective stimuli

    … and a single, 200mg dose of the COMT inhibitor tolcapone on tests of emotional processing. I used the Oxford P1Vital emotional test battery (ETB) and an affective startle reflex modulation (ASRM) paradigm to detect attentional bias and emotional reactivity in the processing of affective stimuli. …

    oxford Repository record for The role of catechol-O-methyltransferase in processing affective stimuli (opens in a new tab)

  5. Separate and interactive effects of catechol-o-methyltransferase and tetrahydrocannabinol on frontostriatal dopamine function

    … mice. Following acute COMT inhibition with tolcapone, THC increased extracellular dopamine levels in the nucleus accumbens in tolcapone-, but not in vehicle-, treated mice. The introduction of the low activity Met allele into the COMT gene produced a highly specific, novel mouse model of the …

    oxford Repository record for Separate and interactive effects of catechol-o-methyltransferase and tetrahydrocannabinol on frontostriatal dopamine function (opens in a new tab)

  6. The magnetoencephalographic signature of catechol-O-methyltransferase

    … dose of the brain-penetrant COMT inhibitor tolcapone (200mg) or placebo. They completed the N-back task of working memory, an emotional face processing task, and a gambling task, in a magnetoencephalography (MEG) scanner, allowing both behavioural performance and neural activity to be …

    oxford Repository record for The magnetoencephalographic signature of catechol-O-methyltransferase (opens in a new tab)

  7. Synthesis and evaluation of nitrocatechol derivatives of chalcone as inhibitors of monoamine oxidase and catechol-O-methyltransferase

    … and benserazide), and COMT inhibitors (tolcapone and entacapone) will block the peripheral action of AADC and COMT, thereby reducing the conversion of levodopa to dopamine. A larger fraction of levodopa is thus available to cross the blood-brain barrier. In the central nervous system, …

    nwu-za Repository record for Synthesis and evaluation of nitrocatechol derivatives of chalcone as inhibitors of monoamine oxidase and catechol-O-methyltransferase (opens in a new tab)

  8. Investigation of the Mechanism of Idiosyncratic Drug-Induced Liver Injury by Immune System Modulation

    … other does not (troglitazone/pioglitazone and tolcapone/entacapone). Overall, I have shown that risk of developing IDILI may be influenced by previous exposures, and I have further developed a model of IDILI, showing its potential for other drugs and as a tool for drug screening. Further …

    toronto-retro Repository record for Investigation of the Mechanism of Idiosyncratic Drug-Induced Liver Injury by Immune System Modulation (opens in a new tab)

  9. Design, synthesis and evaluation of 3-hydroxypyridin-4-ones as inhibitors of catechol-O-methyltransferase

    … Nitrocatechol COMT inhibitors, such as tolcapone and entacapone, have been used in the treatment of Parkinson's disease. Poor bioavailability and undesirable side-effect profiles sometimes limit the clinical use of nitrocatechol COMT inhibitors. The aim of this study therefore was to …

    nwu-za Repository record for Design, synthesis and evaluation of 3-hydroxypyridin-4-ones as inhibitors of catechol-O-methyltransferase (opens in a new tab)

  10. Evaluation of selected dye compounds as inhibitors of enzymes, relevant to neurological disorders

    … also tested and were found to inhibit XO, with tolcapone displaying an IC50 value of 40.9 μM. This study shows that several of the dye compounds inhibit AChE, BuChE, DAAO and DAO. Methylene green, new methylene blue N and Nile blue are particularly noteworthy because these compounds possess IC50 …

    nwu-za Repository record for Evaluation of selected dye compounds as inhibitors of enzymes, relevant to neurological disorders (opens in a new tab)

  11. The synthesis and evaluation of dual inhibitors of monoamine oxidase and catechol-O-methyltransferase

    … Since COMT inhibitors currently on the market (tolcapone and entacapone) contain the nitrocatechol moiety, this structural feature was also incorporated into the chalcones synthesised in this study. The chalcones were thus also investigated as potential COMT inhibitors with the aim of …

    nwu-za Repository record for The synthesis and evaluation of dual inhibitors of monoamine oxidase and catechol-O-methyltransferase (opens in a new tab)

  12. Discovery of catechol-O-methyltransferase inhibitors through virtual screening

    … efficacy. Currently used COMT inhibitors include tolcapone and entacapone. However, due to the side effects, which may include severe dopaminergic, gastrointestinal and other adverse reactions, their use is rather limited. Based on the considerations above, this study aimed to identify compounds …

    nwu-za Repository record for Discovery of catechol-O-methyltransferase inhibitors through virtual screening (opens in a new tab)

  13. Η προπαλμική αναστολή ως ενδοφαινότυπος για ψύχωση: η επίδραση γενετικών πολυμορφισμών που εμπλέκονται στην σχιζοφρένεια, επί της προπαλμικής αναστολής

    Η προπαλμική αναστολή (ΠΠΑ) αναφέρεται στο φαινόμενο της δραστικής μείωσης του ακουστικού αντακλαστικού αιφνιδιασμού (acoustic startle) όταν 30-500 ms πρίν απο το εκλυτικό ερέθισμα προηγείται ένα ασθενές ερέθισμα (ο προπαλμός) που απο μόνο του δέν έχει κανένα αποτέλεσμα στο ανακλαστικό …

    greece Repository record for Η προπαλμική αναστολή ως ενδοφαινότυπος για ψύχωση: η επίδραση γενετικών πολυμορφισμών που εμπλέκονται στην σχιζοφρένεια, επί της προπαλμικής αναστολής (opens in a new tab)